Sandbox Financial Partners’s Pacific Biosciences PACB Stock Holding History

Sandbox Financial Partners’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.3K	Hold	27,517	–	–	0.01%	116
2025 Q4	$51.5K	Hold	27,517	–	–	0.01%	122
2025 Q3	$35.2K	Hold	27,517	–	–	0.01%	127
2025 Q2	$34.1K	Hold	27,517	–	–	0.01%	120
2025 Q1	$32.5K	Buy	+27,517	New	+$42.2K	0.01%	106
2024 Q4	–	Sell	-24,000	Closed	-$40.8K	–	112
2024 Q3	$40.8K	Hold	24,000	–	–	0.01%	107
2024 Q2	$32.9K	Hold	24,000	–	–	0.01%	96
2024 Q1	$90K	Hold	24,000	–	–	0.04%	96
2023 Q4	$235K	Hold	24,000	–	–	0.11%	78
2023 Q3	$200K	Hold	24,000	–	–	0.11%	82
2023 Q2	$319K	Hold	24,000	–	–	0.17%	70
2023 Q1	$278K	Hold	24,000	–	–	0.17%	70
2022 Q4	$196K	Hold	24,000	–	–	0.14%	83
2022 Q3	$139K	Hold	24,000	–	–	0.1%	78
2022 Q2	$106K	Hold	24,000	–	–	0.08%	82
2022 Q1	$218K	Hold	24,000	–	–	0.12%	84
2021 Q4	$491K	Buy	+24,000	New	+$579K	0.31%	39

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sandbox Financial Partners's PACB Position: Q1 2026 in Review

Sandbox Financial Partners held its Pacific Biosciences (PACB) position steady in Q1 2026 at 27,517 shares worth $36.3K. The position accounts for 0.01% of the portfolio, ranked #116.

Sandbox Financial Partners first reported a position in PACB in Q4 2021 and has held it in 17 quarters since. The position peaked at $491K in Q4 2021. 231 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

Sandbox Financial Partners held 27,517 shares of Pacific Biosciences worth $36.3K as of Q1 2026.
Sandbox Financial Partners left its Pacific Biosciences share count unchanged in Q1 2026.
Pacific Biosciences made up 0.01% of Sandbox Financial Partners's portfolio in Q1 2026, its #116 holding.
Sandbox Financial Partners first reported a position in Pacific Biosciences in Q4 2021 and has held it in 17 quarters since.
Sandbox Financial Partners's Pacific Biosciences position peaked at $491K in Q4 2021.
231 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Sandbox Financial Partners's 13F filing for Q1 2026, filed 8 Apr 2026.